Lucien Roulet1, Françoise Ballereau2, Jean-Benoît Hardouin3, Anne Chiffoleau4, Gilles Potel1, Nathalie Asseray5. 1. Emergency Department, Teaching Hospital, Nantes, France; UPRES EA 3826, Faculty of Medical Sciences, Nantes, France. 2. UPRES EA 3826, Faculty of Medical Sciences, Nantes, France; Medqual, Teaching Hospital, Nantes, France. 3. UPRES EA 4275, Biostatistics, Clinical Research and Subjective Measures in Health Sciences, Faculty of Pharmaceutical Sciences, Nantes, France; Plateform of Biometry, Teaching Hospital, Nantes, France. 4. Department of Clinical Pharmacology, Teaching Hospital, Nantes, France. 5. UPRES EA 3826, Faculty of Medical Sciences, Nantes, France; Infectious Diseases Department, Teaching Hospital, Nantes, France.
Abstract
BACKGROUND: Many adverse drug events (ADEs) are not identified by emergency physicians. Research has been done to study risk factors for ADEs and help emergency physicians diagnose ADEs. However, no research has specifically examined the causes underlying a lack of attribution of ADEs to medications in emergency department (ED) patients. OBJECTIVE: We conducted an exploratory study in a medical ED to search for the factors associated with ADE nonrecognition that are related to ED patients and ADEs. METHODS: We conducted an observational study in the medical ED of a French tertiary care hospital between January and December 2009. The study focused on all ADEs, whether or not they were related to the patient's chief complaint. ADEs were identified by an expert physician and pharmacist based on National Electronic Injury Surveillance System criteria. An ADE was considered "attributed" if any evidence of ADE suspicion, ADE diagnosis, or ADE management was documented on ED charts. Factors associated with ADE nonrecognition were identified using multiple logistic regression analysis. RESULTS: Of the 465 included patients, 90 experienced an ADE at ED visit (19.4%; 95% confidence interval [CI] 15.9%-23.2%). Emergency physicians correctly recognized 36 of these cases (40.0%; 95% CI 29.8%-50.9%). On multivariate analysis, ADE nonrecognition was significantly associated with the following variables: nonrelation between the ADE and the patient's chief complaint; daily prescription of four drugs or more; and hospitalization ADE severity category. CONCLUSIONS: Our results emphasize the importance of searching for ADEs in patients with daily polypharmacy or whose chief complaint does not seem to be drug related.
BACKGROUND: Many adverse drug events (ADEs) are not identified by emergency physicians. Research has been done to study risk factors for ADEs and help emergency physicians diagnose ADEs. However, no research has specifically examined the causes underlying a lack of attribution of ADEs to medications in emergency department (ED) patients. OBJECTIVE: We conducted an exploratory study in a medical ED to search for the factors associated with ADE nonrecognition that are related to ED patients and ADEs. METHODS: We conducted an observational study in the medical ED of a French tertiary care hospital between January and December 2009. The study focused on all ADEs, whether or not they were related to the patient's chief complaint. ADEs were identified by an expert physician and pharmacist based on National Electronic Injury Surveillance System criteria. An ADE was considered "attributed" if any evidence of ADE suspicion, ADE diagnosis, or ADE management was documented on ED charts. Factors associated with ADE nonrecognition were identified using multiple logistic regression analysis. RESULTS: Of the 465 included patients, 90 experienced an ADE at ED visit (19.4%; 95% confidence interval [CI] 15.9%-23.2%). Emergency physicians correctly recognized 36 of these cases (40.0%; 95% CI 29.8%-50.9%). On multivariate analysis, ADE nonrecognition was significantly associated with the following variables: nonrelation between the ADE and the patient's chief complaint; daily prescription of four drugs or more; and hospitalization ADE severity category. CONCLUSIONS: Our results emphasize the importance of searching for ADEs in patients with daily polypharmacy or whose chief complaint does not seem to be drug related.
Authors: Corinne M Hohl; Nilu Partovi; Isabella Ghement; Maeve E Wickham; Kimberlyn McGrail; Lisa N Reddekopp; Boris Sobolev Journal: PLoS One Date: 2017-02-13 Impact factor: 3.240
Authors: Roxana De Las Salas; Javier Eslava-Schmalbach; Claudia Vaca-González; Dolores Rodríguez; Albert Figueras Journal: Pharm Pract (Granada) Date: 2020-12-04
Authors: Vera Logan; Sarah Keeley; Kevin Akerman; Elyne De Baetselier; Tinne Dilles; Nia Griffin; Lisa Matthews; Bart Van Rompaey; Sue Jordan Journal: Nurs Open Date: 2020-10-24
Authors: Sue Jordan; Timothy Banner; Marie Gabe-Walters; Jane M Mikhail; Gerwyn Panes; Jeff Round; Sherrill Snelgrove; Mel Storey; David Hughes Journal: PLoS One Date: 2019-09-11 Impact factor: 3.240